FEMY

FEMY

Femasys Inc

Net β€”top 1%Rev β€”top 1%5Y
Hold

Femasys Inc. develops diagnostic and therapeutic solutions for women’s healthcare, including products for reproductive issues. Its offerings include FemaSeed for insemination, FemVue for fallopian tube assessment, and FemBloc for permanent birth control.

βš•οΈ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago β†’$16today

Score Overview

1 Year
Score
Net Growth1.00%
Net TrendGrew
Net Income Consistencyβ€”
Rev Growth40.77%
Rev TrendGrew
Revenue Consistencyβ€”
5 Years
Scoreβ€”
Net Growthβ€”
Net Trendβ€”
Net Income Consistencyβ€”
Rev Growthβ€”
Rev Trendβ€”
Revenue Consistencyβ€”
All Time
Score
Net Growth-147.12%
Net Trend25%
Net Income Consistency
Rev Growth94.40%
Rev Trend75%
Revenue Consistency

See the full market ranking β†’

Femasys Inc fundamental performance

Across Femasys Inc's full reported history, from 2021 to 2025, revenue grew from $ 1M to $ 2M and net income went from -$ 7M to -$ 18M. Revenue increased in 75% of the years measured; net income in 25%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 2.35β€”
1 Year2025-08-12
$ 14.60-83.90%
5 Years2021-08-12
$ 143.80-98.37%
All Time2021-06-18
$ 240.00-99.02%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2025$ 2M-$ 18M$ 9M
2024$ 1M-$ 18M$ 3M
2023$ 1M-$ 14M$ 21M
2022$ 1M-$ 11M$ 12M
IPO2021$ 1M-$ 7M$ 24M

Explore beyond FEMY

You're looking at Femasys Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies